Investigation of the effects of vanilloids in chronic fatigue syndrome.
To assess the effectiveness of TRPV1 modulators in animal model of Chronic fatigue syndrome (CFS). To assess central and peripheral behavioral activity of TRPV1 modulators.



CFS was induced by forcing the rats to swim for 10min for 21 consecutive days. The rats were treated with capsaicin (TRPV1 agonist, 2.5mg/kg) and n-tert-butylcyclohexanol (TRPV1 antagonist, 10mg/kg) for 21days 30min before the exposure to stress procedure. The behavioral consequence of CFS was measured in terms of immobility time, grip strength, locomotor activity, and anxiety level using Rota rod, Actophotometer, and Elevated plus maze model respectively. The other parameters include Plasma corticosterone, adrenal gland and spleen weight, complete blood count, blood urea niterogen (BUN), Lactate dehydrogenase (LDH), Lipid peroxidation, catalase and reduced glutathione (GSH).



TRPV1 modulators reversed (p<0.05) the increase in immobility period, anxiety, spleen weight, BUN and LDH levels, and MDA levels along with decrease in grip strength, locomotor activity, plasma corticosterone, adrenal gland weight, catalase, and GSH. There was also significant increase in total WBC count when compared with the disease control group. The reversal was attributed to modulation of HPA axis, oxidative stress, anaerobic respiration product, muscle degradation product.



The present study reveals the effectiveness of n-tert-butylcyclohexanol and capsaicin against chronic fatigue syndrome. The mechanism of action can be attributed to inhibition of TRPV1 channel and thereby modulating pain perception, neuroendocrine function, oxidative stress and immune function.
Department of Pharmacology, L.M. College of Pharmacy, Ahmedabad, 380009 Gujarat, India. Electronic address: Sarvaiyakuldeep5393@gmail.com.
Kuldeep
K
Sarvaiya
Department of Pharmacology, L.M. College of Pharmacy, Ahmedabad, 380009 Gujarat, India.
Sunita
S
Goswami
D000818:Animals; D001007:Anxiety / Q000188:drug therapy / Q000378:metabolism; D001921:Brain / Q000187:drug effects / Q000378:metabolism; D002211:Capsaicin / Q000494:pharmacology; D003345:Corticosterone / Q000097:blood; D004195:Disease Models, Animal; D015673:Fatigue Syndrome, Chronic / Q000188:drug therapy* / Q000378:metabolism / Q000473:pathology; D009043:Motor Activity / Q000187:drug effects / Q000502:physiology; D018377:Neurotransmitter Agents / Q000494:pharmacology*; D009929:Organ Size; D018384:Oxidative Stress / Q000187:drug effects / Q000502:physiology; D017208:Rats, Wistar; D013154:Spleen / Q000187:drug effects / Q000473:pathology; D013315:Stress, Psychological / Q000188:drug therapy / Q000378:metabolism / Q000473:pathology; D013550:Swimming; D050916:TRPV Cation Channels / Q000819:agonists / Q000037:antagonists & inhibitors* / Q000378:metabolism
D018377:Neurotransmitter Agents; D050916:TRPV Cation Channels; D002211:Capsaicin; D003345:Corticosterone
Chronic fatigue syndrome; Fatigue; Forced swimming test; TRPV1 channel; Vanilloids